Your browser doesn't support javascript.
loading
Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC.
Strell, Carina; Norberg, Karin Jessica; Mezheyeuski, Artur; Schnittert, Jonas; Kuninty, Praneeth R; Moro, Carlos Fernández; Paulsson, Janna; Schultz, Nicolai Aagaard; Calatayud, Dan; Löhr, Johannes Matthias; Frings, Oliver; Verbeke, Caroline Sophie; Heuchel, Rainer Lothar; Prakash, Jai; Johansen, Julia Sidenius; Östman, Arne.
Afiliación
  • Strell C; Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institutet, Stockholm 17176, Sweden.
  • Norberg KJ; Department of Clinical Intervention and Technology (CLINTEC), Center for Digestive Diseases, Karolinska University Hospital and Division of Surgery, Karolinska Institutet, Stockholm 14186, Sweden.
  • Mezheyeuski A; Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institutet, Stockholm 17176, Sweden.
  • Schnittert J; Department of Biomaterials Science and Technology, Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Zuidhorst building, ZH254, Enschede 7500AE, The Netherlands.
  • Kuninty PR; Department of Biomaterials Science and Technology, Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Zuidhorst building, ZH254, Enschede 7500AE, The Netherlands.
  • Moro CF; Department of Laboratory Medicine (LabMed) Division of Pathology, Karolinska Institutet, Stockholm 14186, Sweden.
  • Paulsson J; Department of Clinical Pathology/Cytology, Karolinska University Hospital, Stockholm 14186, Sweden.
  • Schultz NA; Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institutet, Stockholm 17176, Sweden.
  • Calatayud D; Department of Surgical Gastroenterology and Transplantation, Rigshospitalet, Copenhagen University Hospital, Copenhagen 2100, Denmark.
  • Löhr JM; Department of Surgical Gastroenterology and Transplantation, Rigshospitalet, Copenhagen University Hospital, Copenhagen 2100, Denmark.
  • Frings O; Department of Clinical Intervention and Technology (CLINTEC), Center for Digestive Diseases, Karolinska University Hospital and Division of Surgery, Karolinska Institutet, Stockholm 14186, Sweden.
  • Verbeke CS; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm 17176, Sweden.
  • Heuchel RL; Institute of Clinical Medicine, University of Oslo, Postbox 1171 Blindern, Oslo 0318, Norway.
  • Prakash J; Department of Pathology, Oslo University Hospital, Rikshospitalet, Postbox 4956 Nydalen, Oslo 0424, Norway.
  • Johansen JS; Department of Clinical Intervention and Technology (CLINTEC), Center for Digestive Diseases, Karolinska University Hospital and Division of Surgery, Karolinska Institutet, Stockholm 14186, Sweden.
  • Östman A; Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institutet, Stockholm 17176, Sweden.
Br J Cancer ; 117(1): 65-77, 2017 Jun 27.
Article en En | MEDLINE | ID: mdl-28524160

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Neoplasias del Conducto Colédoco / Carcinoma Ductal Pancreático / Proteína HMGA2 Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Neoplasias del Conducto Colédoco / Carcinoma Ductal Pancreático / Proteína HMGA2 Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido